Literature DB >> 3431832

Iodine-125 radiation of posterior uveal melanoma.

S Packer1.   

Abstract

Twenty-eight cases of posterior choroidal melanoma were treated with iodine-125 in gold eye plaques. Eleven cases were located within 3.0 mm of the optic nerve (group A), nine were within 3.0 mm of the fovea (group B), and eight were within 3.0 mm of the optic nerve and fovea (group C). The mean follow-up of group A was 46.3 months; group B, 25.5 months; and group C, 42.7 months. Complications included macular edema, cataract and tumor growth. Visual acuity remained within two lines of that tested preoperatively for 4 of 11 patients in group A, 4 of 9 in group B, and 5 of 8 in group C. These results with iodine-125 suggest it as an appropriate treatment for patients with choroidal melanoma located near optic nerve and/or macula.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3431832     DOI: 10.1016/s0161-6420(87)33241-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

3.  Radiation-induced optic neuropathy following brachytherapy of uveal melanomas.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

4.  Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.

Authors:  P K Lommatzsch; W Alberti; R Lommatzsch; F Rohrwacher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

5.  An Infrared Dye-Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma.

Authors:  Rhonda C Kines; Isabella Varsavsky; Sanghamitra Choudhary; Debaditya Bhattacharya; Sean Spring; Roger McLaughlin; Shin J Kang; Hans E Grossniklaus; Demetrios Vavvas; Stephen Monks; John R MacDougall; Elisabet de Los Pinos; John T Schiller
Journal:  Mol Cancer Ther       Date:  2017-12-14       Impact factor: 6.261

6.  Choroidoretinal neovascularisation following radon seed treatment of retinoblastoma in two patients.

Authors:  D B Archer; W M Amoaku; G Kelly
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

7.  Novel low-kVp beamlet system for choroidal melanoma.

Authors:  Carlos Esquivel; Clifton D Fuller; Robert G Waggener; Adrian Wong; Martin Meltz; Melissa Blough; Tony Y Eng; Charles R Thomas
Journal:  Radiat Oncol       Date:  2006-09-11       Impact factor: 3.481

Review 8.  Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions.

Authors:  Beatrice Y Brewington; Yusra F Shao; Fredrick H Davidorf; Colleen M Cebulla
Journal:  Clin Ophthalmol       Date:  2018-05-17

9.  Long-term followup comparing two treatment dosing strategies of (125) I plaque radiotherapy in the management of small/medium posterior uveal melanoma.

Authors:  Timothy G Murray; Arnold M Markoe; Aaron S Gold; Fiona Ehlies; Ernesto Bermudez; Andrea Wildner; Azeema Latiff
Journal:  J Ophthalmol       Date:  2013-02-28       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.